Antioxidant status and biomarkers of oxidative stress in dogs with lymphoma

Journal of Veterinary Internal Medicine

Volumn 23, Issue 2, 2009, Pages 311-316

  Winter, J L ^a   Barber, L G ^a   Freeman, L ^a   Griessmayr, P C ^a   Milbury, P E ^b   Blumberg, J B ^b  

^a TUFTS UNIVERSITY   (United States)

^b TUFTS UNIVERSITY   (United States)

Author keywords

Cancer; Chemotherapy; Dietary supplements; Nutrition

Indexed keywords

ANIMALIA; CANIS FAMILIARIS;

ALPHA TOCOPHEROL; ANTINEOPLASTIC AGENT; ANTIOXIDANT; GAMMA TOCOPHEROL; GLUTATHIONE PEROXIDASE; ISOPROSTANE DERIVATIVE; MALONALDEHYDE; TUMOR MARKER;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; DOG; DOG DISEASE; DRUG EFFECT; FEMALE; LYMPHOMA; MALE; METABOLISM; OXIDATIVE STRESS; PHYSIOLOGY; PROSPECTIVE STUDY;

ALPHA-TOCOPHEROL; ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIOXIDANTS; DOG DISEASES; DOGS; FEMALE; GAMMA-TOCOPHEROL; GLUTATHIONE PEROXIDASE; ISOPROSTANES; LYMPHOMA; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; PROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 66149153134     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2009.0273.x     Document Type: Article

References (34)

1. Valko M, Leibfritz L, Moncol J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007;39:44-84.
2. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 2002;82:47-95.
3. Dalle-Donne I, Rossi R, Colombo R, et al. Biomarkers of oxidative damage in human disease. Clin Chem 2006;52:601-623.
4. Dhalla NS, Temsah RM, Netticadan T. Role of oxidative stress in cardiovascular diseases. J Hypertens 2000;18:655-673.
5. Jenner P, Olanow CW. The pathogenesis of cell death in Parkinson's disease. Neurology 2006;66:S24-S36.
6. Freeman LM, Brown DJ, Rush JE. Assessment of degree of oxidative stress and antioxidant concentrations in dogs with idiopathic dilated cardiomyopathy. J Am Vet Med Assoc 1999;215: 644-646.
7. Freeman LM, Rush JE, Milbury PE, Blumberg JB. Antioxidant status and biomarkers of oxidative stress in dogs with congestive heart failure. J Vet Intern Med 2005;19:537-541.
8. Walker T, Chan DL, Freeman LM, et al. Serial determination of biomarkers of oxidative stress and antioxidant status in dogs with naturally occurring gastric dilatation-volvulus. J Vet Emerg Crit Care 2007;17:250-256.
9. Vajdovich P, Kriska T, Mezes M, et al. Redox status of dogs with non-hodgkin lymphomas: An ESR study. Cancer Lett 2005; 224:339-346.
10. Szczubial M, Kankofer M, Lopuszynski W, et al. Oxidative stress parameters in bitches with mammary gland tumours. J Vet Med A Physiol Pathol Clin Med 2004;51:336-340.
11. Karihtala P, Soini Y. Reactive oxygen species and antioxidant mechanisms in human tissues and their relation to malignancies. APMIS 2007;115:81-103.
12. Bickers DR, Athar M. Oxidative stress in the pathogenesis of skin disease. J Invest Dermatol 2006;126:2565-2575.
13. Fry FH, Jacob C. Sensor/effector drug design with potential relevance to cancer. Curr Pharm Des 2006;12:4479-4499.
14. Deepa PR, Varalakshmi P. Protective effect of low molecular weight heparin on oxidative injury and cellular abnormalities in adriamycin-induced cardiac and hepatic toxicity. Chem Biol Interact 2003;146:201-210.
15. Yanez JA, Teng XW, Roupe KA, et al. Chemotherapy induced gastrointestinal toxicity in rats: Involvement of mitochondrial DNA, gastrointestinal permeability and cyclooxygenase-2. J Pharm Pharm Sci 2003;6:308-314.
16. Conklin KA. Dietary antioxidants during cancer chemotherapy: Impact on chemotherapeutic effectiveness and development of side effects. Nutr Cancer 2000;37:1-18.
17. D'Andrea GM. Use of antioxidants during chemotherapy and radiotherapy should be avoided. CA Cancer J Clin 2005;55: 319-321.
18. Moss RW. Do antioxidants interfere with radiation therapy for cancer? Integr Cancer Ther 2007;6:281-292.
19. Block KI, Koch AC, Mead MN, et al. Impact of antioxidant supplementation on chemotherapeutic efficacy: A systematic review of the evidence from randomized controlled trials. Cancer Treat Rev 2007;33:407-418.
20. Owen LN., (ed). Lymphoid and hematopoietic tissues (including lymphosarcoma). In: TNM Classification of Tumours in Domestic Animals. Geneva: World Health Organization; 1980: 46-47.
21. Biere JG, Catignani GL. Simultaneous determination of α-tocopherol and retinol in plasma or red cells by high pressure liquid chromatography. Am J Clin Nutr 1979;32:2143-2149.
22. Pleban PA, Munyani A, Beachum J. Determination of selenium concentration and glutathione peroxidase activity in plasma and erythrocytes. Clin Chem 1982;28:311-316.
23. Huang D, Ou B, Hampsch-Woodill M, et al. High-throughput assay of oxygen radical absorbance capacity (ORAC) using a multichannel liquid handling system coupled with a microplate fluorescence reader in 96-well format. J Agric Food Chem 2002; 50:4437-4444.
24. Behrens W, Madere R. Malondialdehyde determination in tissues and biological fluids by ion pairing high performance liquid chromatography. Lipids 1999;26:232-236.
25. Sacheck JM, Milbury PE, Cannon JG, et al. Effect of vitamin E and eccentric exercise on selected biomarkers of oxidative stress in young and elderly men. Free Radic Biol Med 2003;34:1575-1588.
26. Walter MF, Blumberg JB, Dolnikowski GG, et al. Streamlined F2-isoprostane analysis in plasma and urine with highperformance liquid chromatography and gas chromatography/mass spectroscopy. Anal Biochem 2000;280:73-79.
27. Lee YJ, Shacter E. Oxidative stress inhibits apoptosis in human lymphoma cells. J Biol Chem 1999;274:19792-19798.
28. Lee YJ, Shacter E. Hydrogen peroxide inhibits activation, not activity, of cellular caspase-3 in vivo. Free Radic Biol Med 2000;29:684-692.
29. Shacter E, Williams JA, Hinson RM, et al. Oxidative stress interferes with cancer chemotherapy: Inhibition of lymphoma cell apoptosis and phagocytosis. Blood 2000;96:307-313.
30. Pastore A, Federici G, Bertini E, Piemonte F. Analysis of glutathione: Implication in redox and detoxification. Clin Chim Acta 2003;333:19-39.
31. Pastore A, Tozzi G, Gaeta LM, et al. Glutathione metabolism and antioxidant enzymes in children with Down syndrome. J Pediatr 2003;142:583-585.
32. Guven M, Ozturk B, Sayal A, Ozet A. Lipid peroxidation and antioxidant system in the blood of patients with Hodgkin's Disease. Clin Biochem 2000;33:209-212.
33. Abou-Seif MAM, Rabia A, Nasr M. Antioxidant status, erythrocyte membrane lipid peroxidation and osmotic fragility in malignant lymphoma patients. Clin Chem Lab Med 2000;38: 737-742.
34. Erhola M, Kellokumpu-Lehtinen P, Metsa-Ketela T, et al. Effects of anthracyclin-based chemotherapy on total plasma antioxidant capacity in small cell lung cancer patients. Free Radic Biol Med 1996;21:383-390.